Glyscend Therapeutics
Biotechnology
600 Suffolk St
9 employees
- Employees
- 9
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Glyscend Therapeutics Overview
- Headquarters
- 600 Suffolk St
- Website
- glyscend.com
- Industry
- Biotechnology
- Employees
- 9
- Founded
- 2014
- Funding
- 19.8M
- Company Email
- Available in AeroLeads
About Glyscend Therapeutics
Developer of oral, gut-targeted polymer therapeutics for the treatment of metabolic indications such as type 2 diabetes, and other chronic conditions. The company is developing a lead drug, which is orally administered, non-absorbed, gut-restricted duodenal exclusion therapy designed to replicate the metabolic effects of bariatric surgery with safety-advantages avoiding invasive complications of surgeries and procedures.
Glyscend Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Glyscend Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Sarah Mchugh | Sarah Mchugh Consulting | Carlsbad, California, United States |
Email
|
| Bob Sacchiero | Senior Scientist, Preclinical Pharmacology and Drug Discovery | Waltham, Massachusetts, United States |
Email
Phone
|
| Sajida Rahman | Greater Chicago Area, United States |
Email
|
|
| Pankaj Jay Pasricha | Chair Department of Medicine Mayo Clinic, Associate Director Business Development |
View
|
Employees by Management Level
Individual contributor
3 profiles
Director
1 profile
Senior / Lead
1 profile
Glyscend Therapeutics Tech Stack
Data / AI
2 profiles
Compare Similar Companies to Glyscend Therapeutics
REGENXBIO
Biotechnology Research
Biomea Fusion
Biotechnology Research
RoosterBio Inc.
Biotechnology Research
Cerevance
Biotechnology Research
Cellphire Therapeutics, Inc.
Biotechnology Research
DiogenX
Biotechnology
Atrogi
Pharmaceutical Manufacturing
Hememics Biotechnologies, Inc.
Biotechnology Research
Glycologix
Biotechnology
Imcyse SA
Biotechnology Research